ARM works with manufacturing and technology experts to reduce barriers to product development and scale. Projects like A-Cell and A-Gene are addressing challenges related to CMC programs for both cell and gene therapies.
ARM hosts dynamic CMC and scientific workshops to review current industry best practices and shared learnings. We also facilitate ARM-FDA Scientific Exchanges on challenging issues, such as potency assay requirements and building block/platform technologies. ARM is also working with members to map the current landscape and identify key strategies and practices to fill anticipated gaps in skills, education, and diversity.
WHITEPAPER:
WHITEPAPER:
WHITEPAPER:
WHITEPAPER:
